We are live on ! Find out more
ABBV icon

AbbVie

1,286 hedge funds and large institutions have $44.6B invested in AbbVie in 2013 Q2 according to their latest regulatory filings, with 1,286 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

68.14% more ownership

Funds ownership: 0%68.14% (+68%)

33% more call options, than puts

Call options by funds: $182M | Put options by funds: $137M

Holders
1,286
Holders Change
+1,286
Holders Change %
% of All Funds
41.97%
Holding in Top 10
39
Holding in Top 10 Change
+39
Holding in Top 10 Change %
% of All Funds
1.27%
New
1,286
Increased
Reduced
Closed
Calls
$182M
Puts
$137M
Net Calls
+$45.2M
Net Calls Change
+$45.2M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
PFBT
876
Parkside Financial Bank & Trust
Missouri
$887K +$938K +21,446 New
PP
877
Prospector Partners
Connecticut
$885K +$936K +21,400 New
Grantham, Mayo, Van Otterloo & Co (GMO)
878
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$881K +$932K +21,300 New
RIA
879
Regal Investment Advisors
Michigan
$880K +$931K +21,290 New
WA
880
WBH Advisory
Maryland
$878K +$929K +21,244 New
MC
881
Middleton & Co
Massachusetts
$877K +$928K +21,225 New
TSW
882
Thompson Siegel & Walmsley
Virginia
$874K +$925K +21,152 New
ANBTV
883
American National Bank & Trust (Virginia)
Virginia
$873K +$924K +21,133 New
WCM
884
Weston Capital Management
California
$870K +$920K +21,045 New
GIP
885
Greatmark Investment Partners
Georgia
$869K +$919K +21,023 New
Verition Fund Management
886
Verition Fund Management
Connecticut
$869K +$920K +21,029 New
AWCI
887
Alpine Woods Capital Investors
New York
$869K +$920K +21,033 New
EVC
888
Eidelman Virant Capital
Missouri
$864K +$914K +20,900 New
SCM
889
Stonebridge Capital Management
California
$863K +$913K +20,883 New
TWA
890
TCI Wealth Advisors
Arizona
$862K +$911K +20,840 New
1SB
891
1ST Source Bank
Indiana
$862K +$912K +20,858 New
SSWM
892
Sheets Smith Wealth Management
North Carolina
$859K +$909K +20,774 New
SC
893
Schulhoff & Co
Ohio
$856K +$906K +20,705 New
PWP
894
Private Wealth Partners
California
$852K +$901K +20,600 New
AAM
895
Augustine Asset Management
Florida
$848K +$897K +20,519 New
BDF
896
Balasa Dinverno & Foltz
$843K +$892K +20,401 New
EM
897
Excalibur Management
Massachusetts
$836K +$885K +20,225 New
GIM
898
Guardian Investment Management
California
$831K +$875K +20,000 New
OMCS
899
Old Mutual Customised Solutions
South Africa
$831K +$879K +20,100 New
STMM
900
South Texas Money Management
Texas
$829K +$877K +20,056 New

ABBV Hedge Fund Activity: Q2 2013 in Review

1,286 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2013, worth a combined $44.6B.

Buyers outnumbered sellers: 1,286 funds opened new ABBV positions and 0 closed out — a net gain of 1,286 holders — while 0 added to existing stakes and 0 trimmed.

  • 1,286 institutional investors held AbbVie (ABBV) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.6B of AbbVie stock for Q2 2013.
  • 1,286 funds opened new AbbVie positions in Q2 2013 and 0 closed out, a net change of +1,286 holders.

Based on aggregated 13F filings for Q2 2013.